Concepts (82)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Rheumatology | 4 | 2020 | 1213 | 1.16 | Why? |
| Publishing | 6 | 2020 | 990 | 0.77 | Why? |
| Journal Impact Factor | 2 | 2018 | 134 | 0.75 | Why? |
| Authorship | 2 | 2018 | 240 | 0.72 | Why? |
| Plagiarism | 2 | 2020 | 53 | 0.72 | Why? |
| Rheumatic Diseases | 4 | 2021 | 2675 | 0.67 | Why? |
| Periodicals as Topic | 4 | 2020 | 1492 | 0.50 | Why? |
| Blood Platelets | 2 | 2020 | 1704 | 0.44 | Why? |
| Bibliometrics | 1 | 2018 | 731 | 0.41 | Why? |
| Endothelium, Vascular | 1 | 2020 | 1751 | 0.37 | Why? |
| Immunoglobulins, Intravenous | 1 | 2020 | 2705 | 0.35 | Why? |
| Thrombophilia | 1 | 2020 | 1935 | 0.35 | Why? |
| Research Personnel | 1 | 2018 | 1037 | 0.34 | Why? |
| Autoimmune Diseases | 1 | 2021 | 1996 | 0.33 | Why? |
| Scientific Misconduct | 2 | 2020 | 101 | 0.33 | Why? |
| Databases, Bibliographic | 2 | 2018 | 182 | 0.32 | Why? |
| Lymphocytes | 1 | 2019 | 3056 | 0.31 | Why? |
| Peer Review, Research | 2 | 2020 | 407 | 0.28 | Why? |
| Editorial Policies | 2 | 2018 | 408 | 0.24 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.22 | Why? |
| Thrombosis | 2 | 2021 | 7504 | 0.22 | Why? |
| Blood Viscosity | 1 | 2020 | 71 | 0.20 | Why? |
| Plasminogen Activator Inhibitor 1 | 1 | 2020 | 162 | 0.19 | Why? |
| Open Access Publishing | 2 | 2020 | 116 | 0.19 | Why? |
| Education, Distance | 1 | 2020 | 4956 | 0.19 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.19 | Why? |
| Touch | 1 | 2020 | 180 | 0.19 | Why? |
| Scholarly Communication | 1 | 2020 | 123 | 0.18 | Why? |
| Achievement | 1 | 2017 | 28 | 0.18 | Why? |
| Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | 1 | 2021 | 235 | 0.17 | Why? |
| Giant Cell Arteritis | 1 | 2019 | 137 | 0.17 | Why? |
| Medication Therapy Management | 1 | 2020 | 312 | 0.16 | Why? |
| Methotrexate | 1 | 2020 | 471 | 0.16 | Why? |
| Platelet Activation | 1 | 2020 | 660 | 0.15 | Why? |
| Pneumonia, Viral | 8 | 2020 | 243684 | 0.14 | Why? |
| Fibrinogen | 1 | 2020 | 1048 | 0.14 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.13 | Why? |
| Research Report | 1 | 2018 | 376 | 0.13 | Why? |
| Tissue Plasminogen Activator | 1 | 2020 | 778 | 0.13 | Why? |
| Colchicine | 1 | 2020 | 730 | 0.13 | Why? |
| Extracellular Traps | 1 | 2021 | 1036 | 0.12 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.11 | Why? |
| Platelet Aggregation Inhibitors | 1 | 2020 | 1671 | 0.10 | Why? |
| Pandemics | 9 | 2021 | 389249 | 0.10 | Why? |
| Fibrinolytic Agents | 1 | 2020 | 1702 | 0.09 | Why? |
| Antirheumatic Agents | 2 | 2020 | 3023 | 0.09 | Why? |
| Social Media | 2 | 2020 | 5798 | 0.09 | Why? |
| Immunity | 1 | 2020 | 2651 | 0.09 | Why? |
| Heparin | 1 | 2020 | 2600 | 0.08 | Why? |
| Software | 1 | 2017 | 2501 | 0.07 | Why? |
| Information Dissemination | 1 | 2020 | 2986 | 0.07 | Why? |
| Fibrin Fibrinogen Degradation Products | 1 | 2020 | 5993 | 0.07 | Why? |
| Societies, Medical | 1 | 2020 | 6907 | 0.07 | Why? |
| Angiotensin Receptor Antagonists | 1 | 2020 | 3892 | 0.07 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.07 | Why? |
| Humans | 13 | 2021 | 930598 | 0.06 | Why? |
| Communication | 1 | 2020 | 5206 | 0.06 | Why? |
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 5277 | 0.06 | Why? |
| Drug Repositioning | 1 | 2020 | 5683 | 0.06 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.05 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 6653 | 0.05 | Why? |
| Antibodies, Antineutrophil Cytoplasmic | 1 | 2021 | 140 | 0.05 | Why? |
| Anti-Inflammatory Agents | 1 | 2019 | 6153 | 0.05 | Why? |
| Anticoagulants | 1 | 2020 | 9563 | 0.05 | Why? |
| Peer Review | 1 | 2020 | 204 | 0.04 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Biomarkers | 1 | 2019 | 23361 | 0.04 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.04 | Why? |
| Child | 1 | 2021 | 70012 | 0.03 | Why? |
| Neoplasms | 1 | 2019 | 17251 | 0.03 | Why? |
| Adult | 3 | 2021 | 244371 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.02 | Why? |
| Patient Selection | 1 | 2020 | 4560 | 0.02 | Why? |
| Neutrophils | 1 | 2021 | 5476 | 0.02 | Why? |
| Surveys and Questionnaires | 2 | 2020 | 43792 | 0.02 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Risk Factors | 1 | 2021 | 71621 | 0.01 | Why? |
| Middle Aged | 1 | 2020 | 270681 | 0.00 | Why? |
| Male | 1 | 2020 | 367725 | 0.00 | Why? |
| Female | 1 | 2020 | 380317 | 0.00 | Why? |
Gasparyan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(82)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(8)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_